203 related articles for article (PubMed ID: 2045130)
1. Differential presentation of hepatitis B S-preS(2) particles and peptides by macrophages and B-cell like antigen-presenting cells.
Scheerlinck JP; Burssens G; Brys L; Michel A; Hauser P; De Baetselier P
Immunology; 1991 May; 73(1):88-94. PubMed ID: 2045130
[TBL] [Abstract][Full Text] [Related]
2. Antigen presentation to T cell lines and clones by peritoneal macrophages, peritoneal B cells and antigen-specific B cell hybridomas.
Zimecki M; Abruzzini AF; Pierce CW; Kapp JA
Arch Immunol Ther Exp (Warsz); 1988; 36(4):409-22. PubMed ID: 2471477
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells.
Guéry JC; Adorini L
J Immunol; 1995 Jan; 154(2):536-44. PubMed ID: 7529278
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity in antigen processing by different types of antigen-presenting cells. Effect of cell culture on antigen processing ability.
Vidard L; Rock KL; Benacerraf B
J Immunol; 1992 Sep; 149(6):1905-11. PubMed ID: 1517561
[TBL] [Abstract][Full Text] [Related]
5. Capacity of antigen uptake by B cells, fibroblasts or macrophages determines efficiency of presentation of a soluble self antigen (C5) to T lymphocytes.
Stockinger B
Eur J Immunol; 1992 May; 22(5):1271-8. PubMed ID: 1577067
[TBL] [Abstract][Full Text] [Related]
6. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
7. Characterization of antigen processing and presentation by resting B lymphocytes.
Gosselin EJ; Tony HP; Parker DC
J Immunol; 1988 Mar; 140(5):1408-13. PubMed ID: 3257975
[TBL] [Abstract][Full Text] [Related]
8. Wortmannin, an inhibitor of phospholipase D activation, selectively blocks major histocompatibility complex class II-restricted antigen presentation.
Carrasco-Marín E; Alvarez-Domínguez C; Leyva-Cobián F
Eur J Immunol; 1994 Sep; 24(9):2031-9. PubMed ID: 8088323
[TBL] [Abstract][Full Text] [Related]
9. Antigen presentation by hapten-specific B lymphocytes. II. Specificity and properties of antigen-presenting B lymphocytes, and function of immunoglobulin receptors.
Abbas AK; Haber S; Rock KL
J Immunol; 1985 Sep; 135(3):1661-7. PubMed ID: 2410498
[TBL] [Abstract][Full Text] [Related]
10. Time dependence of B cell processing and presentation of peptide and native protein antigens.
Lakey EK; Casten LA; Niebling WL; Margoliash E; Pierce SK
J Immunol; 1988 May; 140(10):3309-14. PubMed ID: 2834435
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
[TBL] [Abstract][Full Text] [Related]
12. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
Dang LH; Lien LL; Benacerraf B; Rock KL
J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of thymus-independent type 2 antigens on MHC class II-restricted antigen presentation: comparative analysis of carbohydrate structures and the antigen presenting cell.
González-Fernández M; Carrasco-Marín E; Alvarez-Domínguez C; Outschoorn IM; Leyva-Cobián F
Cell Immunol; 1997 Feb; 176(1):1-13. PubMed ID: 9070312
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity in cellular antigen retention structures.
Betancourt SV; Solvay MJ; Irani DN; Thomas DW; Nairn R
J Immunol; 1987 Dec; 139(11):3725-9. PubMed ID: 3680948
[TBL] [Abstract][Full Text] [Related]
15. Macrophages, but not dendritic cells, present collagen to T cells.
Michaëlsson E; Holmdahl M; Engström A; Burkhardt H; Scheynius A; Holmdahl R
Eur J Immunol; 1995 Aug; 25(8):2234-41. PubMed ID: 7545114
[TBL] [Abstract][Full Text] [Related]
16. Differential requirements for the processing and presentation of soluble and particulate bacterial antigens by macrophages.
Ziegler HK; Orlin CA; Cluff CW
Eur J Immunol; 1987 Sep; 17(9):1287-96. PubMed ID: 3115792
[TBL] [Abstract][Full Text] [Related]
17. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
Snider DP; Segal DM
J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
[TBL] [Abstract][Full Text] [Related]
18. Leishmania major interferes with antigen presentation by infected macrophages.
Fruth U; Solioz N; Louis JA
J Immunol; 1993 Mar; 150(5):1857-64. PubMed ID: 8436821
[TBL] [Abstract][Full Text] [Related]
19. Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes.
Prina E; Jouanne C; de Souza Lão S; Szabo A; Guillet JG; Antoine JC
J Immunol; 1993 Aug; 151(4):2050-61. PubMed ID: 8102156
[TBL] [Abstract][Full Text] [Related]
20. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
